Clinical Trial Update: HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing HLA 10/10 matched unrelated donor versus haploidentical allogeneic hematopoietic stem cell transplantation for acute leukemias is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Syndromes

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 3 | Status: UNKNOWN